Cas:34658-66-7 2-(4-Bromophenyl)imidazo[1,2-a]pyridine manufacturer & supplier

Chemical Name:2-(4-Bromophenyl)imidazo[1,2-a]pyridine

CAS.NO:34658-66-7

Synonyms:2-(4-bromophenyl)imidazol[1,2-a]pyridine;2-(4-Brom-phenyl)-imidazo[1,2-a]pyridin;2-(4-Bromo-phenyl)-imidazo[1,2-a]pyridine;2-(2-CYCLOHEXYLETHOXY)-5-FLUOROANILINE;2-(4-bromophenyl)H-imidazo[1,2-a]pyridine;MFCD00218250

Molecular Formula:C₁₃H₉BrN₂

Molecular Weight:273.12800

HS Code:2933990090

Physical and Chemical Properties:

Melting point:216-220 °C

Boiling point:N/A

Density:1.48g/cm3

Index of Refraction:1.676

PSA:17.30000

Exact Mass:271.99500

LogP:3.76380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2-(4-bromophenyl)imidazol[1,2-a]pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00218250 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-Bromo-phenyl)-imidazo[1,2-a]pyridine Use and application,2-(4-Bromo-phenyl)-imidazo[1,2-a]pyridine technical grade,usp/ep/jp grade.

Related News: Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes. 2-(4-Bromophenyl)imidazo[1,2-a]pyridine manufacturer Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 2-(4-Bromophenyl)imidazo[1,2-a]pyridine supplier ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. 2-(4-Bromophenyl)imidazo[1,2-a]pyridine vendor Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 2-(4-Bromophenyl)imidazo[1,2-a]pyridine factory Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.